Robotic Surgery Devices Market Report 2026

Robotic Surgery Devices Market Overview

• Robotic Surgery Devices market size has reached to $8.81 billion in 2025 • Expected to grow to $18.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.4% • Growth Driver: Rise In Demand For Minimally Invasive Technology Driving Market Growth Due To Enhanced Surgical Precision And Patient Outcomes • Market Trend: Launching Advanced Robotic Platforms To Enhance Precision, Safety, And Patient Outcomes • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Robotic Surgery Devices Market?

Robotic surgery devices help doctors perform complex minimally invasive operations with precision and flexibility. The main products and services in the robotic surgery devices market are robotic systems, instruments and accessories, and services. The services are provided by the robots and are also called robot-assisted surgery services. The various surgery types are urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These are used in hospitals and ambulatory surgery centers.

What Is The Robotic Surgery Devices Market Growth Forecast?

The robotic surgery devices market size is expected to see rapid growth in the next few years. It will grow to $18.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing adoption of autonomous surgical functions, rising demand for precision surgery, expansion of robotic surgery training programs, growing integration of ai-assisted decision support, increasing outpatient robotic procedures. Major trends in the forecast period include increasing adoption of robot-assisted minimally invasive surgeries, rising demand for multi-specialty robotic platforms, growing use of advanced surgical visualization systems, expansion of remote and teleoperated surgery, enhanced focus on surgical precision and outcomes.

What Is The Driver Of The Robotic Surgery Devices Market?

The rise in demand for minimally invasive technology is expected to propel the robotic surgery devices market going forward. Minimally invasive technology refers to surgical procedures performed through small incisions using advanced instruments and robotic systems that reduce tissue damage and recovery time. This rise in demand for minimally invasive technology is due to patient preference for faster recovery, reduced post-operative complications, and shorter hospital stays. The rise in demand for minimally invasive technology supports the robotic surgery devices market by boosting adoption of robotic-assisted platforms that enhance precision, enable complex procedures, and improve overall surgical outcomes. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the rise in demand for minimally invasive technology is driving the growth of the robotic surgery devices industry.

Key Players In The Global Robotic Surgery Devices Market

Major companies operating in the robotic surgery devices market are Intuitive Surgical Inc., Stryker Corporation, Medtronic plc, Smith & Nephew plc, Johnson & Johnson, TransEnterix Inc., Zimmer Biomet Holdings Inc., Auris Health Inc., CMR Surgical Ltd., Verb Surgical Inc., Renishaw plc, Think Surgical Inc., Corindus Vascular Robotics Inc., Mazor Robotics Ltd., Titan Medical Inc., Virtual Incision Corporation, Medrobotics Corporation, Preceyes BV, Microbot Medical Inc., Asensus Surgical Inc., Avatera Medical GmbH, Medicaroid Corporation, Hansen Medical Inc., Edge Surgical Inc., Synaptive Medical, Aesculap Inc.

Global Robotic Surgery Devices Market Trends and Insights

Major companies operating in the robotic surgery devices market are focusing on technological advancements, such as robotic surgery platforms, to increase procedural efficiency, treatment precision, and overall profitability. Robotic surgery platforms are being designed to reduce radiation exposure, improve ergonomics for surgeons, and enhance patient recovery through minimally invasive procedures. R-One+ is a medical robot system for heart surgery. For instance, in May 2023, Robocath, a France-based medical technology company launched R-One+, a new robot system for heart surgery. The R-One+ robotic platform is intended to increase treatment precision and safety, lessen radiation exposure, and improve patient experience in general. Using a tablet and a joystick, the robotic solution enables interventional cardiologists to carry out coronary angioplasties. A noteworthy development in the field of interventional cardiology is the R-One+ robotic platform, which gives doctors a new tool to enhance patient outcomes and lower the risk of problems during treatments.

What Are Latest Mergers And Acquisitions In The Robotic Surgery Devices Market?

In October 2025, Zimmer Biomet Holdings, Inc., a US based medical technology company, completed the acquisition of Monogram Technologies for an undisclosed amount. With this acquisition, Zimmer Biomet aims to expand its robotic surgery devices market presence by integrating Monogram’s semi autonomous and fully autonomous robotic systems, specifically its CT based, artificial intelligence (AI)-navigated total knee arthroplasty technology into its ROSA Robotics platform and navigation portfolio. Monogram Technologies, Inc. is a US-based company developing surgeon guided semi and fully autonomous robotic technologies for orthopedic surgery, particularly focused on total knee arthroplasty.

What Defines the Robotic Surgery Devices Market?

Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Robotic Surgery Devices Market Report 2026?

The robotic surgery devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.